Emily Bodnar's Stock Ratings

HC Wainwright & Co. Analyst

Emily Bodnar is an analyst at HC Wainwright & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/08/2024

Overall Average Return

-8.69%

Smart Score

48.4%

Overall Average Return Percentile

22nd

Number of Ratings

142
No data available to display
date
▲▼
ticker
▲▼
Buy Now
Company
▲▼
Current price
▲▼
Upside/Downside
▲▼
Analyst Firm
▲▼
Analyst & % Accurate
▲▼
Price Target Change
▲▼
Rating Change
▲▼
Previous / Current Rating
▲▼
Get Alert

Recent Analyst Stock Rating News

Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
Unveiling 8 Analyst Insights On NovoCure
Peeling Back The Layers: Exploring NovoCure Through Analyst Insights
FedEx To Rally Over 32%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
These Analysts Revise Their Forecasts On Nkarta After Q4 Results
Nkarta, Inc. (NASDAQ: NKTX) posted a loss for the fourth quarter on Thursday.
Visa To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
What's Going On With Femasys Stock?
Femasys Inc. (NASDAQ: FEMY) shares are up more than 14% on Monday and have gained more than 900% over the last five days. Here's a look at what's going on:
Why Femasys Inc Stock Is Roaring Higher
Femasys Inc. (NASDAQ: FEMY) shares are trading higher Friday after HC Wainwright maintained a Buy rating on the stock and raised its price target from $5 to $13.
Nike To Rally Around 53%? Here Are 10 Other Analyst Forecasts For Friday
Piper Sandler cut the price target for Accenture plc (NYSE: ACN) from $312 to $300. Piper Sandler analyst Arvind Ramnani maintained a Neutral rating. Accenture shares rose 0.3% to $301.56 in pre-market trading.
Despite Trial Setback For Acelyrin's Lead Program, Analyst Shows Optimism
Acelyrin Inc (NASDAQ: SLRN) announced topline results from Part B of a Phase 2b/3 trial evaluating izokibep for moderate-to-severe Hidradenitis Suppurativa (HS). 
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free